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Mutant keratins 5 or 14 are implicated in the etiology of
epidermolysis bullosa simplex (EBS). The catalog of
mutations has established certain patterns of mutation
clusters from which it may be possible, along with
associated biochemical data, to predict phenotypic sever-
ity. It is becoming apparent that some of these assump-
tions may now require modification. We report a
mutation in the gene encoding keratin 14 (KRT14) that
changes the predicted amino acid at position 119, at the
start of the helix initiation motif, from methionine to
threonine (K14 M119T) in a patient with an EBS Dowling–
Research over recent years has demonstrated that eachof the epidermolysis bullosa simplex (EBS) subtypesis associated with mutations in the genes encodingbasal keratinocyte keratins 5 or 14, KRT5 or KRT14,respectively (for review see Corden and McLean,
1996). Mutational analysis combined with supportive biochemical
assembly data led to the development of certain guidelines predictive
of disease severity. Generally, mutations in the ends of the central rod
domain or the helix initiation or termination motifs of either keratin,
are associated with the most severe phenotype, EBS Dowling–Meara
(EBS-DM), whereas those in the nonhelical head, or linker domain
are predictive of phenotypes of EBS Ko¨bner or EBS Weber–Cockayne
(for examples see Corden and McLean 1996).
As an increasing volume of mutation data accumulates, genotype to
phenotype correlations appear less clear cut; with recessive (Hovnanian
et al, 1993) as well as dominant inheritance, dosage effects (Hu et al,
1997), and recessive null mutations (Chan et al, 1994; Rugg et al,
1994; Jonkman et al, 1996; Corden et al, 1998) we are recognizing an
increasingly complex pattern of keratin behavior in the disease state.
We report a case of EBS-DM with severe palmo-plantar hyperker-
atosis with a mutation in KRT14, where the location of the protein
defect is of secondary importance to the resultant amino acid change.
It is also one of three reported mutations affecting one codon that
independently result in all three major subtypes of EBS. This may
reflect that different subtypes of EBS should be considered as gradients
of severity possibly dependent on multiple factors.
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Meara phenotype with severe palmo-plantar hyperker-
atosis. This demonstrates that the three major types of
EBS can arise from missense mutations in the same
codon. The findings suggest that the specific nature of
the missense mutation, in the context of the protein
sequence, can contribute far more to the clinical severity
than previously thought. The different EBS subtypes
should be viewed as gradations of clinical severity rather
than distinct genetic diseases. Key words: blistering skin
diseases/keratin intermediate filaments/helix initiation motif. J
Invest Dermatol 111:893–895, 1998
MATERIALS AND METHODS
Case report The proband is a 41 y old man whose case has been included
previously in two brief reports (Tidman et al, 1987).1 He had widespread skin
fragility and blistering from birth. From early childhood he developed gross
palmoplantar hyperkeratosis resulting in flexion contratures of the hands and
considerable functional and cosmetic difficulties (Fig 1). The patient’s siblings
and parents were clinically normal.
Mutation analysis The first exon of the KRT14 genomic DNA was
polymerase chain reaction amplified using sense primer 59-TAC CCG AGC
ACC TTC TCT TC-39 (257–276 bp, accession #J00124) and anti-sense primer
59-TGC TGG AGA ACA AGT AGC TGC-39 (1223–1202 bp). Approximately
500 ng DNA was used per 100 µl reaction containing 60 mM Tris-HCl pH 9.5,
15 mM (NH4)2SO4, and 2.5 mM MgCl2, 0.2 mM each dNTP, 0.5 µg per ml
each primer, and 2.5 U Taq polymerase (Perkin-Elmer, Warrington, U.K.).
Polymerase chain reaction conditions were 94°C for 1 min followed by 30
cycles of 30 s at 94°C, 1 min at 55°C, and 2 min at 72°C, followed by 7 min
at 72°C. This fragment was used in sequencing and in the screen. Cycle
sequencing of template was performed using sense primer 59-GGG GGA GCC
TAT GGG TTG GGG-39 (496–516 bp) and the ABI PRISM Dye Terminator
Cycle Sequencing Ready Reaction Kit for sequencing on an ABI DNA
sequencer.
A smaller fragment for restriction analysis was reamplified from the initial
gel purified fragment by use of sense primer (496–516 bp) and anti-sense primer
59-GAT CTT CAC TTC CAG GTC GGC-39 (759–739 bp) as above. Products
were precipitated using ammonium acetate and resuspended in 10 µl water.
One-tenth of the product was incubated at 60°C for 15 min in a reaction
consisting of 5 mM spermidine, 5 U Nla III at 37°C overnight in the buffer
supplied (NEB).
Light microscopy and electron microscopy Skin samples were processed
for transmission electron microscopy using methods largely as described previ-
1Archer CB, Holden CA, Wells RS: Epidermolysis bullosa (Dowling–Meara).
Br J Dermatol 109:58, 1983 (abstr.)
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ously (Eady, 1985), including primary fixation in half-strength Karnovsky
fixative (containing 2% formaldehyde and 2.5% glutaraldehyde in 0.04 M
cacodylate buffer), and secondary fixation in 1.3% osmium tetroxide in distilled
water. Samples were dehydrated in ethanol and embedded in Epon resin. Semi-
thin sections were stained with Richardson’s stain (Richardson et al, 1960) and
viewed by light microscopy. Ultra-thin sections were stained with uranyl acetate
and lead citrate and observed with a JEOL 100CX transmission electron
microscope.
Figure 1. Hyperkeratosis of the palm. The patient demonstrates marked
palmar hyperkeratosis despite previous long-term oral corticosteroid treatment
and surgical excision of hyperkeratotic skin. Photograph taken at age 38 y.
Figure 2. Severe keratin intermediate filament disruption in epidermis.
Electron microscopy of clinically uninvolved skin from the upper arm reveals
keratin intermediate filament disruption. Keratin intermediate filaments
(tonofilaments) show clumping (arrows) beneath the nucleus (N) of a basal
epidermal cell with evidence of early cytolysis (*), confirming a diagnosis of
EBS-DM. Scale bar: 1 µm.
RESULTS
Light and electron microscopy findings Light microscopy of
semi-thin sections of skin revealed a low plane of cleavage through
the epidermal basal layer. Numerous intracytoplasmic inclusions were
evident in both intact and disrupted basal and suprabasal cells. Electron
microscopy confirmed the presence of lysis of the basal layer and
demonstrated that the cytoplasmic masses were clumped keratin tonofi-
laments (Fig 2). The frequency of keratin aggregates and filament
lumps was high in both basal cell layers and the first suprabasal cell layer.
Figure 3. An automated sequence chromatograph. Sequence
chromatographs generated from the cycle sequencing of the KRT14 gene with
a sense primer show (A) the heterozygous change from a T to a C in the
second position of codon 119 (K14M119T) versus (B) the control sequence.
Both individuals show a homozygous polymorphic variation of a G to a A in
the third position of codon 120 that does not alter the amino acid glutamine.
Nucleotides identifying the signal peaks are indicated directly above the peaks
and the corresponding amino acid above the first letter of the codon. The
altered nucleotide and amino acid are above the respective normal sequence.
The standard one letter abbreviation for the amino acid is given.
Figure 4. Restriction digest to demonstrate association of the mutation
with the EBS-phenotype. The 264 bp polymerase chain reaction-generated
fragment (lane 12) was excised by Nla III to produce two fragments sized
181 bp and 83 bp if the site at this codon was normal (lanes 1–10). The
mutation knocked out the recognition site resulting in an uncut fragment of
264 bp in one allele of the patient DNA (lane 11). Products were analyzed on
a 4% NuSieve agarose TBE gel.
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A heterozygous point mutation in keratin 14 Sequencing of
kertain 14 genomic DNA from the patient revealed a point mutation
at the second position in codon 119 of one allele (Fig 3), which
changes the predicted amino acid coded from a methionine (ATG) to
a threonine (ACG). The screening of 50 non-EBS patients for the
mutation by restriction digest demonstrates that the mutation is not a
polymorphism and is associated with the disease phenotype (Fig 4).
DNA encoding all of keratin 14 (Marchuk et al, 1985) and the head
and rod of keratin 5 (Eckert and Rorke, 1988; Lersch and Fuchs,
1988) was also sequenced but no other significant deviation from the
published sequences was detected.
DISCUSSION
We report an example of EBS-DM with severe hyperkeratosis associated
with a mutation in one allele of keratin 14 (K14M119T), in a codon
at which previous mutations were associated with a mild phenotype.
With reference to protein structure predictions, position 119 in keratin
14 lies on the boundary between the head domain and the α-helical
rod domain, at the start of the helix initiation motif. The helix initiation
motif sequence is highly conserved across type I keratins and contains
the major hot-spot for EBS mutations (arginine at position 125 in
keratin 14).
K14M119 is itself highly conserved within type I keratins and
changes here have already been shown to be associated with EBS.
These other reports have, however, linked M119 mutations with
different phenotypes to that documented here. The first report described
a heterozygous change from methionine to isoleucine, K14M119I,
associated with EBS Weber-Cockayne (Chen et al, 1995). In a
second report, mutation of M119 to isoleucine was found with
both heterozygous and homozygous expression (Hu et al, 1997):
heterozygosity for the mutation was associated with EBS Weber-
Cockayne, whilst homozygosity for K14M119I was associated with a
more severe EBS Ko¨bner phenotype.
The phenotype of our patient is more severe than these arising from
hetero- or homozygosity for K14M119I, suggesting that K14M119T
on one allele is more disruptive to filament assembly. Therefore, three
different mutations in codon 119 are associated with three different
EBS subtypes, suggesting that the nature of the mutation contributes
greatly to defining the clinical severity. These mutations thus challenge
the belief that clinical severity of EBS is determined simply by the
position at which the mutation occurs, i.e., that mutations in the helix
initiation motif always lead to EBS-DM.
The disruptive potential of a missense EBS mutation often depends
on its position within the keratin protein sequence. In some locations
it seems that any mutation will give rise to a severe phenotype. The
arginine codon 125 in keratin 14 has been subjected to a high degree
of mutation. The phenotype in each case has been EBS-DM with
similar clinical severity. It is possible that the position of the 125th
amino acid residue is so critical that it is unable to tolerate any change
and, therefore, possibly only certain amino acid positions within the
conserved helix termination motifs are absolutely intolerant and any
change will lead to EBS-DM.
In other locations, similar clinical severity results from both hetero-
zygous and homozygous states (e.g., K5K173N, Kobner EBS pheno-
type) (Stephens et al, 1995). Nevertheless the observations presented
here, on this new mutation at the edge of the rod domain of keratin
14, warn against assuming a simple relationship between sequence
position of an EBS mutation and its clinical severity.
Although K14M119T is particularly disruptive to the keratin cyto-
skeleton (as we have observed in transfected cultured cells, C.S.S.
unpublished observations), the hyperkeratosis might be exacerbated by
additional contributory factors from the genetic background of the
individual. Genetic modifiers for keratin disease phenotypes have been
proposed (McLean et al, 1994) but not yet identified (McLean and
Lane, 1995).
This study demonstrates that the three major clinically distinguishable
subtypes of EBS can arise from mutations in the same codon of K14.
The results argue strongly that EBS subtypes constitute different points
on a single severity gradient, rather than distinct, different diseases. A
closer analysis of the conformational implications of threonine versus
isoleucine versus methionine at position 119 in keratin 14 should also
provide interesting information relevant to our understanding of
intermediate filament assembly.
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